Suciraslimab Antibody
Suciraslimab (SM03) is a human IgG1 monoclonal antibody targeting CD22, developed for rheumatoid arthritis and other B-cell mediated disorders. Its research applications include in vitro B-cell depletion assays and in vivo models for autoimmune disease studies.
Product Specifications
Product Name Alternative
SM 03, SM03
Target
Immunology/Inflammation related
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
7.51 mg/mL
Purity
>95.0% (May vary between batches)
Molecular Weight
146.16 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
